View Cart (0 items)

Roche, Merck Collaborate to Develop Cancer Test

February 18, 2010
/ Print / Reprints /
| Share More
/ Text Size+

Swiss drug and medical products company Roche said it is collaborating with Merck & Co. to develop a potential cancer test that could be used to more accurately target therapies, according to the Associated Press. Financial details of the partnership were not disclosed. Roche will provide a Merck unit access to the developing microarray-based AmpliChip p53 Test, which is designed to detect mutations in the tumor suppressor gene p53. The goal is to better identify cancers that affect the gene, allowing companies to better target developing therapies.

You must login or register in order to post a comment.

Related Events